医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

AIDP and Andy Khawaja Conduct New Pandemic Research for AI Technology

2020年09月25日 PM07:00
このエントリーをはてなブックマークに追加


 

BEIJING

Artificial Intelligence Defense Platform, a technology start-up creating AI technology for a safer, more comfortable future, and its Founder Andy Khawaja have created a new department within AIDP that is dedicated to pandemic research to see how AI technology can be most useful in future pandemics.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200925005033/en/

Andy Khawaja - Founder of Artificial Intelligence Defense Platform (Photo: Business Wire)

Andy Khawaja – Founder of Artificial Intelligence Defense Platform (Photo: Business Wire)

In lieu of the Coronavirus Pandemic, or COVID-19, Artificial Intelligence Defense Platform has already found many new ways AI technology can be used for identifying and forecasting pandemic outbreaks. AI technology can track the outbreaks and predict outcomes based on actions.

Andy Khawaja and AIDP have found better methods for tracking carriers based upon tracing data via smartphones, also known as contact tracing.

Although there is a natural resistance to artificial intelligence technology in the healthcare industry, AIDP’s studies show how useful the technology can be in the future to minimize contact when necessary.

“AI technology can perform simple nurse functions to protect our healthcare workers. Machines can check temperatures, administer medicines and treatments, and even perform simple procedures,” says Andy Khawaja.

Dr. Andy Khawaja added, “AI technology has traditionally been met with a level of skepticism and adversity, but we want to show people how it can be useful. We no longer have to serve as the machines when we have the technology to be the operators.”

Artificial Intelligence Defense Platform’s Pandemic Division focuses on AI technology to more accurately diagnose, treat, and cure patients as well as technology to prevent the spread, administer medicine, perform tasks, and process administrative work to better track illnesses and occurrences.

Andy Khawaja says, “The goal is to minimize the effects and longevity of inevitable pandemics and protect populations on a medical and economical level for generations to come.”

About Artificial Intelligence Defense Platform:

Artificial Intelligence Defense Platform is creating new AI technology for compatible systems and machines to build a safer, more sustainable future for mankind. Please visit http://www.ai-dp.com/ for more information.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200925005033/en/

CONTACT

David Herzog

E-mail: support@AI-DP.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  •  Celltrion’s monoclonal antibody treatment for COVID-19, regdanvimab (CT-P59) becomes the first authorized COVID-19 treatment approved from the Korean Ministry of Food and Drug Safety (MFDS)
  • ENHERTU® Reduced the Risk of Disease Progression or Death by 72% Versus Trastuzumab Emtansine (T-DM1) in Patients with HER2 Positive Metastatic Breast Cancer
  • ENHERTU® Demonstrated Clinically Meaningful and Durable Response in Patients with HER2 Positive Advanced Gastric Cancer in DESTINY-Gastric02 Phase 2 Trial
  • 武田的EXKIVITY™ (mobocertinib)成为美国FDA首次核准的专为EGFR外显子20插入+ NSCLC患者设计的口服治疗药物
  • Masimo上市单例患者使用的rainbow® SuperSensor™